IMMUNITYBIO, INC. Property, Plant and Equipment, Gross
IMMUNITYBIO, INC. (IBRX) had Property, Plant and Equipment, Gross of $228.53 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-05-07
- 2026-03-31: Property, Plant and Equipment, Gross $228.53M.
- 2025-12-31: Property, Plant and Equipment, Gross $226.75M.
- 2025-09-30: Property, Plant and Equipment, Gross $238.85M.
- 2025-06-30: Property, Plant and Equipment, Gross $238.88M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-03-31 | $228.53M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $226.75M 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $238.85M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $238.88M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $238.21M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $236.68M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $235.43M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $234.22M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $231.90M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $230.46M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $233.05M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $229.07M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $227.58M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $212.91M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $195.04M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $180.11M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $162.07M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $135.94M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $119.39M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $137.10M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $125.42M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $114.40M 10-K · filed 2022-03-01 | $81.04M 10-K · filed 2021-03-04 |
| 2020-09-30 | $80.70M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $81.68M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $79.36M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $111.63M 8-K/A · filed 2021-04-22 | $79.11M 10-K · filed 2020-03-25 |
| 2019-09-30 | $78.54M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $79.25M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $79.86M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $88.45M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $86.59M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $85.40M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $82.19M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $81.03M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $77.75M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $62.85M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $24.36M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $20.08M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $17.07M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $9.78M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $7.36M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $5.69M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $257.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |